Suchergebnisse - "Bhatt, Anant Narayan"

PubPharm (71)

1

Anti-cancer drug-induced mitochondrial alteration becomes a limitation of metabolic viability-based MTT assay in analyzing growth inhibition

enthalten in: ResearchSquare.com | 2024

von Kumar, A. | Rai, Y. | Bhatt, A.

2

Nanoemulsion potentiates the anti-cancer activity of Myricetin by effective inhibition of PI3K/AKT/mTOR pathway in triple-negative breast cancer cells

enthalten in: Medical oncology (Northwood, London, England) | 2024

von Sharma, P. | Chaturvedi, S. | Khan, M. | +5

3

Nanoemulsion potentiates the anti-cancer activity of Myricetin by effective inhibition of PI3K/AKT/mTOR pathway in triple-negative breast cancer cells

enthalten in: Medical oncology | 2024

von Sharma, P. | Chaturvedi, S. | Khan, M. | +5

4

Biocompatible epoxysilane substituted polymer-based nano biosensing platform for label-free detection of cancer biomarker SP17 in patient serum samples

enthalten in: International journal of biological macromolecules | 2023

von Yadav, A. | Verma, D. | Kumar, A. | +2

5

Ascorbate formulation improves healing efficacy in excisional wound mice model through interplay between pro and anti-inflammatory cytokines and angiogenic markers

enthalten in: Cytokine | 2023

von Kalonia, A. | Kumar Sharma, A. | Shaw, P. | +4

6

Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress : Implications in PAMP-associated acute and chronic pathology

enthalten in: Frontiers in pharmacology | 2023

von Pandey, S. | Anang, V. | Singh, S. | +8

7

A calcium and zinc composite alginate hydrogel for pre-hospital hemostasis and wound care

enthalten in: Carbohydrate polymers | 2023

von Kumar, A. | Sah, D. | Khanna, K. | +4

8

2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19 : a proof-of-concept and dose-ranging randomised phase II clinical trial

enthalten in: BMC infectious diseases | 2022

von Bhatt, A. | Shenoy, S. | Munjal, S. | +6

9

2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial

enthalten in: BMC infectious diseases | 2022

von Bhatt, A. | Shenoy, S. | Munjal, S. | +6

10

2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial

enthalten in: BMC infectious diseases | 2022

von Bhatt, A. | Shenoy, S. | Munjal, S. | +6

1
2
3
4
5
6
7
8
Nächster »
[8]